Navigation Links
Synthetic biology can help extend anti-malaria drug effectiveness
Date:3/6/2009

In addition to providing a simple and much less expensive means of making artemisinin, the most powerful anti-malaria drug in use today, synthetic biology can also help to extend the effectiveness of this drug. Fermenting artemisinin via engineered microbes, such as yeast, can be done at far lower costs than extracting the drug from Artemsisia annua, the sweet wormwood tree, making microbial-based artemisinin a much cheaper but equally effective treatment. Restricting access to this technology to responsible manufacturers who will bundle artemisinin as part of an anti-malarial drug "cocktail" rather than selling it as a monotherapy should delay or even prevent malaria parasites from developing resistance. Recently, there have been reports of malaria parasites in West Africa showing some signs of resistance to artemisinin.

"The problem has been that some manufacturers have sold artemisinin as a monotherapy rather than as a co-therapy as is recommended by the World Health Organization," said Jay Keasling, a chemical engineer with joint appointments at Berkeley Lab and UC Berkeley, who led the development of this microbial-based method of producing artemisinin. "Any drug that is used as a monotherapy raises the possibility of microbes developing resistance to it. Right now artemisinin is grown by farmers all over the world and sold to anybody. Through the synthetic biology technique, access to the cheapest artemisinin can be restricted to manufacturers who agree to sell it as part of a co-therapy drug."

Keasling, who is one of the world's leading researchers in synthetic biology and CEO of the Joint BioEnergy Institute (JBEI), one of three U.S. Department of Energy Bioenergy Research Centers, made his remarks at a press briefing at the annual meeting of the American Association for the Advancement of Science (AAAS). At the symposium on Synthetic Life, he gave a talk entitled: Synthetic Biology in Pursuit of Low-Cost, Effective, Anti-Mala
'/>"/>

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. Milestone achieved toward production of malaria treatment using synthetic biology and fermentation
2. Synthetic biology key in the 21st century
3. Synthetic biology: Is ethics a showstopper?
4. Synthetic virus supports a bat origin for SARS
5. UNC scientists teach enzyme to make synthetic heparin in more varieties
6. Biosynthetics production with detours
7. Synthetic Biology: Coming Up Fast!
8. Caltech engineers build firast-ever multi-input plug-and-play synthetic RNA device
9. New synthetic form of protein holds promise to stop cancer spread
10. Synthetic moleculues could add spice to fight against cancer
11. Synthetic molecules emulate enzyme behavior for the first time

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Synthetic biology can help extend anti-malaria drug effectiveness
Synthetic biology can help extend anti-malaria drug effectiveness
(Date:11/24/2009)... ROUGE Antarctica has long held secrets of the ea...recently, there has been very little information o...iles of ice for millions of years. Now, a team of ... have been funded to the tune of $10 million dolla...get to the bottom of things literally. These scie...
(Date:11/23/2009)...ATINew research presents strong evidence that the ...h outdoor traffic-related pollution and indoor end...ne or the other exposure alone. , Environmenta...i (UC) College of Medicine have shown that childre...articles and indoor endotoxin during early life ar...
(Date:11/23/2009)... study by the Wildlife Conservation Society says t...mp in the Republic of Congopart of the "mother lod...earare becoming increasingly threatened by growing...mmends protection of the swamp forests adjacent to...after recent surveys confirmed that high densities...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2California American Water Celebrates No Drugs Down the Drain Week in San Diego 6041 1California American Water Celebrates No Drugs Down the Drain Week in San Diego 6041 2A New Era of E Learning in the Comfort and Convenience of Your Home or Office Without the Classroom Environment 60815 1A New Era of E Learning in the Comfort and Convenience of Your Home or Office Without the Classroom Environment 60815 2SleepApneaUSA net Announced An Immediate Alternative Sleep Apnea Solution In Response To The NTSB 26apos 3Bs Sleep Apnea Testing Recommendations 60813 1SleepApneaUSA net Announced An Immediate Alternative Sleep Apnea Solution In Response To The NTSB 26apos 3Bs Sleep Apnea Testing Recommendations 60813 2SleepApneaUSA net Announced An Immediate Alternative Sleep Apnea Solution In Response To The NTSB 26apos 3Bs Sleep Apnea Testing Recommendations 60813 3SleepApneaUSA net Announced An Immediate Alternative Sleep Apnea Solution In Response To The NTSB 26apos 3Bs Sleep Apnea Testing Recommendations 60813 4SleepApneaUSA net Announced An Immediate Alternative Sleep Apnea Solution In Response To The NTSB 26apos 3Bs Sleep Apnea Testing Recommendations 60813 5
...st dangerous form of malaria is difficult to treat...hers at Karolinska Institutet in Sweden have devel... Severe anaemia, respiratory problems and encephal...s of serious malaria infection. The diseases are c...cts the red blood cells, which then accumulate in ...
... can be exposed to methamphetamine or "crystal met...samples, published ahead of print in the Fetal and...ood. , Unlike hair, the most commonly used detect...g term use, nor can they always distinguish among ...aightening the hair will not erase the chemical ev...
...the causes of autism remain complex and mysterious...tricate puzzle. In what they believe to be a signi...rum disorders" (ASD), researchers have developed a... brain hypertrophy characteristic of the disease. ...arada and his colleagues report the results of rem...
Other Biology News:Hair samples show babies can be exposed to 'crystal meth' while in the womb 2Mutant mice show key autism traits 2
(Date:11/24/2009)... Health care employment grew by 2...nly one to show consistent growth during the U.S. ...s remain in trouble, and health systems are coming...l, instead of just administrators. , ...re employment continued growing in October despite...
(Date:11/24/2009)...NMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neurog...ocusedondevelopingandcommercializingnovelpainmanag...esidentandChiefExecutiveOfficer,isscheduledtoprese...tobeheldDecember1-2,2009atTheNewYorkPalaceHotelinN...i,ChiefFinancialOfficer,willbeavailabletorespondto...
(Date:11/24/2009)... The FBI recently approved the Prom... participating in or generating DNA records for th... Madison, WI USA (PRWEB) -- The FBI recently ... for use by laboratories participating in, or gene...tem (NDIS). NDIS currently contains more than seve...
(Date:11/24/2009)...BLIN,November24/PRNewswire-FirstCall/--Shireplc(LS...ceuticalcompany,today,announcedthatithassubmitteda...fa,thecompany,senzymereplacementtherapyindevelopme...hirdmarketing,applicationforvelaglucerasealfathath...dStatesandCanada. , Basedonaglobalsupplyshort...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...-Ever United Nations World Diabetes Day, Experts P...n of UN Resolution on Diabetes, NEW YORK, Nov. 14...nagement today called for an overhaul in the world... and prevention in order to reverse,the rising dia...ited,Nations (UN) World Diabetes Day. In a new pub...
...Nov. 14 Techne Corporation,(Nasdaq: TECH ) today...zed,the repurchase of up to $150 million of the Co...rchase authorization does not have an expiration d...Company spends and the number,of shares it ultimat...ent,and will depend on factors such as current sto...
..., and TORONTO, Nov. 13 /PRNewswire/ - BioRelix, pi...tch based therapeutic agents and,Dalton Medicinal ...boration,to discover new therapeutics. Dalton Med...sights to,design and synthesize several novel clas...ts. BioRelix will advance these compounds using th...
Other Biology Technology:International Diabetes Experts Call for Stepped-Up Action and Shared Responsibility to Curb Rising Global Diabetes Epidemic and Impact 2International Diabetes Experts Call for Stepped-Up Action and Shared Responsibility to Curb Rising Global Diabetes Epidemic and Impact 3International Diabetes Experts Call for Stepped-Up Action and Shared Responsibility to Curb Rising Global Diabetes Epidemic and Impact 4Techne Corporation Announces Share Repurchase Authorization 2BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology 2
Capped Xef-1 RNA 0.05 ml from Ambion
Human TIMP-1 ELISpot Kit from R&D Systems
Chicken Anti-Ras-related C3 botulinum toxin substrate 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Anti-Human sVCAM-1 / CD106 ELI-PAIR Kit Antibody, Unconjugated from Cell Sciences
Biology Products: